🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hey #IDTwitter! How well do you know isavuconazole (ISV)? Follow the🧵to find out. Answer each question then check your answer in the tweet below… No cheating! 3 ID PharmDs @MsSmallsO Dan Ilges @johnsontannerm averaged 7/7 on the following Q's - can you match their score?

I got to celebrate finishing my Grand Rounds on early multimodal vasopressors with a Squeeze Squad pin from Curious Boxwood! Thank you Patrick Wieruszewski, Cassie Schmitt, PharmD, Alicia Mattson, and Francis Manuel for all of your help in preparing for my presentation!

Crit Care Lit Review 📒 Vasopressin 💉 VASST: Adding vaso ⬇️catecholamine dose and may reduce mortality for those with lower NE dose (<15 mcg/min) in septic shock VANISH: Adding vaso early to NE may ⬇️ need for RRT VANCS: Vaso ⬇️acute renal failure in vasoplegic shock #PharmICU

Starting out pharmacy week with many congratulations to pharmacy mentors, preceptors, colleagues, and friends selected for ACCP awards this year! Donna Shuler Truoccolo 🐀 @CBthePHARMD Andrea Nei Scott Nei and JennaKLovelyPharmD

We are recruiting this year for the PGY2 EM program Mayo Clinic Pharmacy Residency Programs! Come join us at a virtual open house on 11/7! @CBthePHARMD Cassie Schmitt, PharmD Kyle Hess Kellyn Engstrom ACCP EMED PRN

🚨🚨 Calling all EM PGY2 Candidates 💊🚑 Are you looking for a pharmacy PGY2 in EM? Consider our program at Mayo Clinic Pharmacy Residency Programs! 👇👇Here's a thread why 👇👇

Dr. Kyle Hess, EM PGY2 resident at Mayo Clinic will present on "Intravenous Thrombolysis with Alteplase at 0.6 mg/kg in Patients with Ischemic Stroke Taking DOAC" published this year in J Am Heart Assoc.

Kyle A. Hess, PharmD Kyle Hess - "Early Multimodal Vasopressors in Septic Shock: When is it Time for Full-Court Press(ors)?". Pharmacology CE available for pharmacists, physicians, physician assistants, and nurse practitioners. #TwitteRx Mayo Clinic Med Ed apple.co/3BgREwB

🆕️⚡️⚡️#JCM JClinMicro EIC Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in MSSA Bacteremia #IDTwitter journals.asm.org/doi/10.1128/jc…

My PGY-1 research project just got published! Thankful for my amazing research mentors ⁦Ryan Stevens⁩ and ⁦Kirstin Kooda⁩ as well as all of ⁦Mayo Clinic Infectious Diseases⁩! journals.asm.org/doi/10.1128/jc…

One day Mayo Clinic Infectious Diseases Twitterless Dan DeSimone and I had a pt w/ persistent MSSA bacteremia on cefazolin and had an ox MIC of 2… we said “right right… the cefazolin shouldn’t be inferior to an ASP… we know the data… but what about the high ox MIC?” journals.asm.org/doi/10.1128/jc…

Hot-off-the-press #AACJournal. Challenging Clinical Case on a patient with S. aureus endocarditis and discrepant mecA/mecC PCR. A rea therapeutic conundrum! ASM ASM Texas Medical Center Chapter journals.asm.org/doi/10.1128/aa…

#IDTwitter will like this case, invoking conversations of BORSA/MODSA and the like. What to do when genotypic and phenotypic testing don't align in Staph aureus?

Publication Alert Description of a case of S. aureus bloodstream infection and infective endocarditis with discordance between mecA/mecC genotypic results and phenotypic susceptibility testing. omar abu saleh Ryan Stevens mayocl.in/3Jurc6q

Kyle A. Hess, PharmD, BCPS - "All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose". Pharmacology CE available for pharmacists, physicians, physician assistants, and nurse practitioners. #TwitteRx Mayo Clinic Med Ed mayocl.in/3JyxDpj

Think you know already know everything about beta-lactam resistance in Staphylococcus aureus? Think twice! In my commentary in #AACJournal I describe the hidden side of oxacillin resistance ASM journals.asm.org/doi/10.1128/aa…

Great debate of what to do with mecA/PBP2A negative, oxacillin-resistant Staph aureus Cx results A: Expert panel rec’s report & treat as MRSA, given highly elevated oxa MIC as opposed to BORSA that traditionally has MIC of 2 or less. Likely explained by blaZ #IDWeek2023